Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. (Q50773267)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2006

Language	Label	Description	Also known as
English	Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.	scientific article published in June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

cerebrospinal fluid

0 references

multiple sclerosis

0 references

Massimiliano Castellazzi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Enrico Granieri

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Tiziana Bellini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Maria Cristina Manfrinato

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

E Fainardi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

E Baldi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

I Casetta

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

E Paolino

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

F Dallocchio

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

294-301

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Inflammation in multiple sclerosis: the good, the bad, and the complex

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS.

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Development of biomarkers in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Decreased MMP-9 production in primary progressive multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1191%2F135248506MS1274OA

21 January 2018

Identifiers

10.1191/135248506MS1274OA

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764342%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50773267&oldid=1106253428"